Modeling the angiotensin-converting enzyme inhibitory activity of peptide mixtures obtained from cheese whey hydrolysates using concentration-response curves

Biotechnology Progress

Volumn 28, Issue 5, 2012, Pages 1197-1206

  Estévez, Natalia ^a   Fuciños, Pablo ^a,b   Sobrosa, Ana C ^a   Pastrana, Lorenzo ^a   Pérez, Nelson ^a   Luisa Rua M ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

Author keywords

Antihypertensive activity; Mathematical modeling; Peptides; Ultrafiltration; Whey proteolysis

Indexed keywords

ACE INHIBITION; ACTIVE PEPTIDES; ADEQUATE MODELS; ANGIOTENSIN-CONVERTING ENZYME; ANTI-HYPERTENSIVE ACTIVITIES; BEST FIT; BIOACTIVE PEPTIDES; CHEESE WHEY; INHIBITORY ACTIVITY; LOGISTIC MODELS; MICHAELIS-MENTEN KINETIC; NEUTRASE; PEPTIDE MIXTURES; PHYSICAL MEANINGS; PROTEIN CONTENTS; REGRESSION COEFFICIENT; WHEY PROTEOLYSIS;

MATHEMATICAL MODELS; MIXTURES; PEPTIDES; PROTEOLYSIS; ULTRAFILTRATION;

ENZYME ACTIVITY;

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MILK PROTEIN; PEPTIDE; PROTEIN HYDROLYSATE; WHEY PROTEIN;

ANIMAL; ARTICLE; CATTLE; CHEESE; CHEMISTRY; HYDROLYSIS; KINETICS; RABBIT; THEORETICAL MODEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CATTLE; CHEESE; HYDROLYSIS; KINETICS; MILK PROTEINS; MODELS, THEORETICAL; PEPTIDES; PEPTIDYL-DIPEPTIDASE A; PROTEIN HYDROLYSATES; RABBITS;

EID: 84867395437     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1587     Document Type: Article

References (43)

1. González Siso MI. The biotechnological utilization of cheese whey: a review. Bioresour Technol. 1996; 57: 1-11.
2. Román A, Wang J, Csanádi J, Hodúr C, Vatai G. Partial demineralization and concentration of acid whey by nanofiltration combined with diafiltration. Desalination. 2009; 241: 288-295.
3. Fajardo P, Fuciños C, Rodríguez I, Pastrana L, Guerra NP. Cheese whey utilization for bacteriocin production. In: Cerdán ME, González-Siso MI, Bacerra M, editors. Advances in Cheese Whey Utilization. Kerala, India: Transworld Research Network; 2008: 163-193.
4. Korhonen H, Pihlanto A. Bioactive peptides: production and functionality. Int. Dairy J. 2006; 16: 945-960.
5. Hîntoiu A, Râpeanu G, Stanciu S, Stanciuc N. The effect of pH and thermal treatment on some functional properties of whey proteins hydrolysates as measured by fluorescence spectroscopy. J Agroaliment Process Technol. 2011; 17: 179-185.
6. Gauthier SF, Pouliot Y. Functional and biological properties of peptides obtained by enzymatic hydrolysis of whey proteins. J Dairy Sci. 2003; 86: E78-E87.
7. Erdmann K, Cheung BWY, Schröder H. The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem. 2008; 19: 643-654.
8. Li G, Le G, Shi Y, Shrestha S. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr Res. 2004; 24: 469-486.
9. Vermeirssen V, Van Camp J, Verstraete W. Optimisation and validation of an angiotensin-converting enzyme inhibition assay for the screening of bioactive peptides. J Biochem Biophys Methods. 2002; 51: 75-87.
10. Fritz M, Vecchi B, Rinaldi G, Añón MC. Amaranth seed protein hydrolysates have in vivo and in vitro antihypertensive activity. Food Chem. 2011; 126: 878-884.
11. Vercruysse L, Smagghe G, Herregods G, Van Camp J. ACE inhibitory activity in enzymatic hydrolysates of insect protein. J Agric Food Chem. 2005; 53: 5207-5211.
12. Pihlanto A, Virtanen T, Korhonen H. Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effect of fermented milk. Int Dairy J. 2010; 20: 3-10.
13. Tsai J, Chen J, Pan BS. ACE-inhibitory peptides identified from the muscle protein hydrolysate of hard clam (Meretrix lusoria). Process Biochem. 2008; 43: 743-747.
14. Ahn JE, Park SY, Atwal A, Gibbs BF, Lee BH. Angiotensin I-converting enzyme (ACE) inhibitory peptides from whey fermented by lactobacillus species. J Food Biochem. 2009; 33: 587-602.
15. Tovar-Pérez EG, Guerrero-Legarreta I, Farrés-González A, Soriano-Santos J. Angiotensin I-converting enzyme-inhibitory peptide fractions from albumin 1 and globulin as obtained of amaranth grain. Food Chem. 2009; 116: 437-444.
16. Guang C, Phillips RD. Purification, activity and sequence of angiotensin converting enzyme inhibitory peptide from alcalase hydrolysate of peanut flour. J Agric Food Chem. 2009; 57: 10102-10106.
17. Shalaby SM, Zakora M, Otte J. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J Diary Res. 2006; 73: 178-186.
18. Li G, Liu H, Shi Y, Le G. Direct spectrophotometric measurement of angiotensin I-converting enzyme inhibitory activity for screening bioactive peptides. J Pharm Biomed Anal. 2005; 37: 219-224.
19. Zhu Z, Qiu N, Yi J. Production and characterization of angiotensin converting enzyme (ACE) inhibitory peptides from apricot (Prunus armeniaca L.) kernel protein hydrolysate. Eur Food Res Technol. 2010; 231: 13-19.
20. Lahogue V, Réhel K, Taupin L, Haras D, Allaume P. A HPLC-UV method for the determination of angiotensin I-converting enzyme (ACE) inhibitory activity. Food Chem. 2010; 118: 870-875.
21. Vermeirssen V, Van Camp J, Augustijns P, Verstraete W. Angiotensin-I Converting Enzyme (ACE) inhibitory peptides derived from pea and whey protein. Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet. 2002; 67: 27-30.
22. Sideridis GD. Data smoothing: prediction of human behavior, detection of behavioral patterns, and monitoring treatment effectiveness in single-subject behavioral studies. J Behav Educ. 1997; 7: 191-203.
23. Guerra NP, Pastrana Castro L. Modelling the effects of ageing time of starch on the enzymatic activity of three amylolytic enzymes. Sci World J. 2012;2:1-13.
24. Levenberg K. A method for the solution of certain problems in least squares. Quart Appl Math. 1944; 2012: 164-168.
25. Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. SIAM J Appl Math. 1963; 11: 431-441.
26. Hernández-Ledesma B, Recio I, Ramos M, Amigo L. Preparation of ovine and caprine β-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine β-lactoglobulin hydrolysed with thermolysin. Int Dairy J. 2002; 12: 805-812.
27. Hernández-Ledesma B, Ramos M, Recio I, Amigo L. Effect of β-lactoglobulin hydrolysis with thermolysin under denaturing temperatures on the release of bioactive peptides. J Chromatogr A. 2006; 1116: 31-37.
28. López-Fandiño R, Otte J, van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J. 2006; 16: 1277-1293.
29. Pripp AH, Sørensen R, Stepaniak L, Sørhaug T. Relationship between proteolysis and angiotensin-I-converting enzyme inhibition in different cheeses. LWT-Food Sci Technol. 2006; 39: 677-683.
30. Otte J, Shalaby SMA, Zakora M, Nielsen MS. Fractionation and identification of ACE-inhibitory peptides from α-lactalbumin and β-casein produced by thermolysin-catalysed hydrolysis. Int Dairy J. 2007; 17: 1460-1472.
31. Lourenço da Costa E, Antonio da Rocha Gontijo J, Netto FM. Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. Int Dairy J. 2007; 17: 632-640.
32. Li GH, Le GW, Liu H, Shi YH. Mung-bean protein hydrolysates obtained with alcalase exhibit angiotensin I-converting enzyme inhibitory activity. Food Sci Technol Int. 2005; 11: 281-287.
33. Roberts PR, Burney JD, Black KW, Zaloga GP. Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract. Digestion. 1999; 60: 332-337.
34. Van der Ven C, Gruppen H, De Bont DBA, Voragen AGJ. Optimisation of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int Dairy J. 2002; 12: 813-820.
35. Murado MA, González MP, Vázquez JA. Dose-response relationships: an overview, a generative model and its application to the verification of descriptive models. Enzyme Microb Technol. 2002; 31: 439-455.
36. Bünning P, Holmquist B, Riordan JF. Substrate specificity and kinetic characteristics of angiotensin converting enzyme. Biochemistry (N.Y.). 1983; 22: 103-110.
37. L'vov VM, Sadykov ÉS. Competitive inhibitors of the angiotensin-converting enzyme from the venom of the viper Echis multisquamatus. Chem Nat Compd. 1999; 35: 332-335.
38. Bala M, Qadar Pasha MA, Bhardwaj DK, Pasha S. Novel peptidomimics as angiotensin-converting enzyme inhibitors: a combinatorial approach. Bioorg Med Chem. 2002; 10: 3685-3691.
39. Byun H, Kim S. Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from alaskan pollack skin. J Biochem Mol Biol. 2002; 35: 239-243.
40. Sturrock ED, Natesh R, Van Rooyen JM, Acharya KR. Structure of angiotensin I-converting enzyme. Cell Mol Life Sci. 2004; 61: 2677-2686.
41. Shapiro R, Riordan JF. Inhibition of angiotensin converting enzyme: dependence on chloride. Biochemistry (N.Y.). 1984; 23: 5234-5240.
42. Pihlanto-Leppälä A, Koskinen P, Phlola K, Tupasela T, Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. J Diary Res. 2000; 67: 53-64.
43. Tavares T, Contreras MDM, Amorim M, Pintado M, Recio I, Malcata FX. Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes. Peptides. 2011; 32: 1013-1019.